Immutep Limited (IMMP): Price and Financial Metrics

Immutep Limited (IMMP): $1.93

0.09 (+4.62%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add IMMP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#271 of 333

in industry

IMMP Price/Volume Stats

Current price $1.93 52-week high $3.34
Prev. close $1.84 52-week low $1.66
Day low $1.87 Volume 182,000
Day high $1.96 Avg. volume 218,114
50-day MA $2.03 Dividend yield N/A
200-day MA $2.34 Market Cap 280.00M

IMMP Stock Price Chart Interactive Chart >


Immutep Limited (IMMP) Company Bio


Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ‘eftilagimod alpha' or ‘efti', which is a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer termed AIPAC and in a Phase I combination therapy trial in metastatic melanoma termed TACTI-mel; and is being evaluated as a combination therapy in head and neck squamous cell carcinoma and non-small cell lung carcinoma in a Phase II clinical trial called TACTI-002 and an investigator initiated Phase I trial called INSIGHT in advanced solid tumors. Its other products include IMP761, IMP701 and IMP731, all of which are related to lymphocyte activation gene 3, a gene linked to the regulation of T cells in immune responses. Immutep Limited has partnerships with GlaxoSmithKline, Novartis, CYTLIMIC Inc., INSIGHT, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.


IMMP Latest News Stream


Event/Time News Detail
Loading, please wait...

IMMP Latest Social Stream


Loading social stream, please wait...

View Full IMMP Social Stream

IMMP Price Returns

1-mo 2.12%
3-mo -20.58%
6-mo N/A
1-year 0.52%
3-year -45.63%
5-year 10.92%
YTD -19.58%
2023 37.14%
2022 -46.65%
2021 4.46%
2020 75.42%
2019 -2.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!